• Press Release
  • Information

LPIXEL Installs the EIRL series at more than 100 Japanese Medical Institutions

Tokyo, Japan – December 17, 2020 – LPIXEL Inc., a leader in image analysis and processing in life science and medical research, is pleased to announce that the cumulative number of clinical installations of the EIRL series, its medical image analysis software, in medical institutions has exceeded 100.
In October 2019, EIRL Brain Aneurysm[1], its medical image analysis software that identifies suspected aneurysms from brain MRI, received the first deep learning-powered software as a medical device (SaMD) for brain MRI, and became commercially available. Starting with this product, LPIXEL has launched 2 medical image analysis software products approved and certified from the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, and 2 medical image analysis software secured the Japanese Pre-Market Certification . EIRL has been widely used from small medical institutions to general hospitals all over Japan.
LPIXEL believes that AI has the potential to make the medical world a better place, and will continue its research and development with receiving feedback from many doctors and medical professionals.

“We have been working closely with doctors to develop EIRL. The doctors work with a strong sense of mission and a nervousness to make an accurate diagnosis. We do believe EIRL can benefit patients by supporting their diagnosis,” says Yuki Shimahara, Chief Executive Officer of LPIXEL Inc.
“While Medical AI is not yet perfect, it is evolving day by day with the support by the doctors who are thinking about their patients earnestly and trying to use AI effectively. We make efforts continuously to create a world where Medical AI becomes the norm, and realize medical care that is kind to both doctors and patients,” he added.

[1] EIRL Brain Aneurysm
Product Name: Medical Image Analysis Software “EIRL aneurysm”
Certification Number: 30100BZX00142000

About EIRL
EIRL is the collective name given to LPIXEL’s AI medical image diagnostic support technology. LPIXEL aims to provide solutions that enable a faster and more accurate diagnosis by implementing its unique algorithms to analyze medical big data, such as brain MRI, chest X-rays, and colonoscopy. For more information, please visit

LPIXEL is a leader in advanced image analysis and processing technology encompassing the life science field. Founded in March 2014, LPIXEL is dedicated to offering research facilities, top-tier image analysis technologies and medical diagnosis technologies, both of which adopt advanced AI technology. LPIXEL revolves around business such as its medical image analysis software, “EIRL,” and its AI-based image analysis cloud service, “IMACEL.”
For more information, please visit

Contact Information


Cutting-Edge Technologies that Lead Future Medical Diagnosis
EIRL analyzes a wide range of medical data to provide an accurate and efficient diagnosis. EIRL aims to be the closest partner to all doctors, and serve as another powerful set of eyes to provide top quality medical care.
AI Accelerating
Phase R&D
IMACEL, an image analysis AI, helps to solve various issues in the drug discovery process.
Life science and AI experts support successful AI implementation.



Alphabetical listing


A Third Career Option for Researchers